Analyzing the protection scope limit for biosequence patent claims in China

Nat Biotechnol. 2018 Sep 6;36(9):811-813. doi: 10.1038/nbt.4234.
No abstract available

MeSH terms

  • Bacteria
  • Biotechnology
  • China
  • Drug Industry / legislation & jurisprudence
  • Economic Competition
  • Europe
  • Glucan 1,4-alpha-Glucosidase / chemistry
  • Legislation, Drug*
  • Mutation
  • Patents as Topic / legislation & jurisprudence*
  • Pharmaceutical Preparations

Substances

  • Pharmaceutical Preparations
  • Glucan 1,4-alpha-Glucosidase